Clinical Endoscopy

  • 제55권2호
  • /
  • Pages.234-239
  • /
  • 2022
  • /
  • 2234-2400(pISSN)
  • /
  • 2234-2443(eISSN)
대한소화기내시경학회 (The Korean Society of Gastrointestinal Endoscopy)
권호 표지
DOI QR코드

DOI QR Code

Propofol Alone versus Propofol in Combination with Midazolam for Sedative Endoscopy in Patients with Paradoxical Reactions to Midazolam

  • 투고 : 2021.04.14
  • 심사 : 2021.05.19
  • 발행 : 2022.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: The efficacy of propofol in gastrointestinal endoscopy for patients with midazolam-induced paradoxical reactions remains unclarified. This study aimed to compare the efficacy and safety of propofol-based sedation in patients who previously experienced paradoxical reactions. Methods: This was a prospective, single-blinded, randomized controlled pilot study. Participants with a history of paradoxical reactions to midazolam during a previous esophagogastroduodenoscopy were recruited and randomly assigned to group I (propofol monosedation) or group II (combination of propofol and midazolam). The primary endpoint was the occurrence of a paradoxical reaction. Results: A total of 30 participants (mean age, 54.7±12.6 years; male, 19/30) were randomly assigned to group I (n=16) or group II (n=14). There were no paradoxical reactions in group I, but there were two in group II, without a significant difference (p=0.209). The mean dose of propofol was higher in group I than in group II (p=0.002). Meanwhile, the procedure and recovery times did not differ between groups. Conclusions: Propofol-based sedation was safe and effective for patients who experienced paradoxical reactions to midazolam. However, caution is needed because few cases of paradoxical reaction again can happen in group II in which midazolam was readministered.

키워드

과제정보

This study was supported by a 2017 Weolbong grant from the Korean Gastrointestinal Endoscopy Research Foundation.

참고문헌

  1. Yi SY, Shin JE. Midazolam for patients undergoing upper gastrointestinal endoscopy: a prospective, single-blind and randomized study to determine the appropriate amount and time of initiation of endoscopy. J Gastroenterol Hepatol 2005;20:1873-1879.  https://doi.org/10.1111/j.1440-1746.2004.04081.x
  2. Valori R, Cortas G, de Lange T, et al. Performance measures for endoscopy services: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J 2019;7:21-44.  https://doi.org/10.1177/2050640618810242
  3. Lee JK, Lee YJ, Cho JH, et al. Updates on the sedation for gastrointestinal endoscopy. Clin Endosc 2019;52:451-457.  https://doi.org/10.5946/ce.2019.172
  4. Tae CH, Kang KJ, Min BH, et al. Paradoxical reaction to midazolam in patients undergoing endoscopy under sedation: incidence, risk factors and the effect of flumazenil. Dig Liver Dis 2014;46:710-715.  https://doi.org/10.1016/j.dld.2014.04.007
  5. Hong GW, Lee JK, Lee JH, et al. Comparison of fentanyl versus meperidine in combination with midazolam for sedative colonoscopy in Korea. Clin Endosc 2020;53:562-567.  https://doi.org/10.5946/ce.2020.022
  6. Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy 2004;24:1177-1185.  https://doi.org/10.1592/phco.24.13.1177.38089
  7. Weinbroum AA, Szold O, Ogorek D, Flaishon R. The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol 2001;18:789-797.  https://doi.org/10.1097/00003643-200112000-00002
  8. Honan VJ. Paradoxical reaction to midazolam and control with flumazenil. Gastrointest Endosc 1994;40:86-88.  https://doi.org/10.1016/S0016-5107(94)70020-6
  9. Rex DK, Deenadayalu VP, Eid E, et al. Endoscopist-directed administration of propofol: a worldwide safety experience. Gastroenterology 2009;137:1229-1237; quiz 1518-1519.  https://doi.org/10.1053/j.gastro.2009.06.042
  10. Lee JK, Jang DK, Kim WH, Kim JW, Jang BI. [Safety of non-anesthesiologist administration of propofol for gastrointestinal endoscopy]. Korean J Gastroenterol 2017;69:55-58.  https://doi.org/10.4166/kjg.2017.69.1.55
  11. Levitzky BE, Lopez R, Dumot JA, Vargo JJ. Moderate sedation for elective upper endoscopy with balanced propofol versus fentanyl and midazolam alone: a randomized clinical trial. Endoscopy 2012;44:13-20.  https://doi.org/10.1055/s-0031-1291421
  12. Poulos JE, Kalogerinis PT, Caudle JN. Propofol compared with combination propofol or midazolam/fentanyl for endoscopy in a community setting. AANA J 2013;81:31-36. 
  13. Khoshoo V, Thoppil D, Landry L, Brown S, Ross G. Propofol versus midazolam plus meperidine for sedation during ambulatory esophagogastroduodenoscopy. J Pediatr Gastroenterol Nutr 2003;37:146-149.  https://doi.org/10.1002/j.1536-4801.2003.tb08132.x
  14. Lee TH, Lee CK, Park SH, et al. Balanced propofol sedation versus propofol monosedation in therapeutic pancreaticobiliary endoscopic procedures. Dig Dis Sci 2012;57:2113-2121.  https://doi.org/10.1007/s10620-012-2234-0
  15. Dumonceau JM, Riphaus A, Aparicio JR, et al. European society of gastrointestinal endoscopy, european society of gastroenterology and endoscopy nurses and associates, and the european society of anaesthesiology guideline: non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy 2010;42:960-974.  https://doi.org/10.1055/s-0030-1255728
  16. Harris ZP, Liu J, Saltzman JR. Quality assurance in the endoscopy suite: sedation and monitoring. Gastrointest Endosc Clin N Am 2016;26:553-562.  https://doi.org/10.1016/j.giec.2016.02.008
  17. McGrath B, Chung F. Postoperative recovery and discharge. Anesthesiol Clin North Am 2003;21:367-386.  https://doi.org/10.1016/S0889-8537(02)00080-9
  18. Golparvar M, Saghaei M, Sajedi P, Razavi SS. Paradoxical reaction following intravenous midazolam premedication in pediatric patients - a randomized placebo controlled trial of ketamine for rapid tranquilization. Paediatr Anaesth 2004;14:924-930.  https://doi.org/10.1111/j.1460-9592.2004.01349.x
  19. Massanari M, Novitsky J, Reinstein LJ. Paradoxical reactions in children associated with midazolam use during endoscopy. Clin Pediatr (Phila) 1997;36:681-684.  https://doi.org/10.1177/000992289703601202
  20. Terui T, Inomata M. Administration of additional analgesics can decrease the incidence of paradoxical reactions in patients under benzodiazepine-induced sedation during endoscopic transpapillary procedures: prospective randomized controlled trial. Dig Endosc 2013;25:53-59.  https://doi.org/10.1111/j.1443-1661.2012.01325.x
  21. Shin S, Oh TG, Chung MJ, et al. Conventional versus analgesia-oriented combination sedation on recovery profiles and satisfaction after ERCP: a randomized trial. PLoS One 2015;10:e0138422. 
  22. VanNatta ME, Rex DK. Propofol alone titrated to deep sedation versus propofol in combination with opioids and/or benzodiazepines and titrated to moderate sedation for colonoscopy. Am J Gastroenterol 2006;101:2209-2217.  https://doi.org/10.1111/j.1572-0241.2006.00760.x
  23. Kiriyama S, Naitoh H, Kuwano H. Propofol sedation during endoscopic treatment for early gastric cancer compared to midazolam. World J Gastroenterol 2014;20:11985-11990.  https://doi.org/10.3748/wjg.v20.i34.11985
  24. Kanno Y, Ohira T, Harada Y, et al. Safety and recipient satisfaction of propofol sedation in outpatient endoscopy: a 24-hour prospective investigation using a questionnaire survey. Clin Endosc 2021;54:340-347.  https://doi.org/10.5946/ce.2020.138
  25. Cohen LB, Wecsler JS, Gaetano JN, et al. Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol 2006;101:967-974.  https://doi.org/10.1111/j.1572-0241.2006.00500.x
  26. Park CH, Han DS, Jeong JY, et al. Outcomes of propofol sedation during emergency endoscopy performed for upper gastrointestinal bleeding. Dig Dis Sci 2016;61:825-834.  https://doi.org/10.1007/s10620-015-3942-z
  27. Lee SH, Lee GM, Lee DR, Lee JU. Factors related to paradoxical reactions during propofol-induced sedated endoscopy. Scand J Gastroenterol 2019;54:371-376. https://doi.org/10.1080/00365521.2019.1585938